Overview

Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

Status:
Unknown status
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analysis the different genotype in the idiopathic membranous nephropathy patients which with different therapeutic outcomes after treated by the Comprehensive Treatment Regimen or immunosuppressive agents, and so as to looking for ideal markers to assess appropriate treatment approach and the long-term efficacy.
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Treatments:
Cyclophosphamide
Cyclosporine
Cyclosporins
Glucocorticoids
Immunosuppressive Agents
Tacrolimus